Real-World Response and Outcomes in Patients With NSCLC With EGFR Exon 20 Insertion Mutations

Real-World Response and Outcomes in Patients With NSCLC With EGFR Exon 20 Insertion Mutations

Introduction: This study describes treatment patterns and outcomes in patients with NSCLC with EGFR exon 20 insertions (EGFRex20ins) in the United States. Methods: The Flatiron Health electronic health record database was used to select three cohorts among patients diagnosed with NSCLC with EGFRex20...

Full description

Bibliographic Details
Main Authors: Sai-Hong Ignatius Ou, MD, Huamao M. Lin, PhD, MBA, Jin-Liern Hong, PhD, Yu Yin, MS, MPH, Shu Jin, MS, Jianchang Lin, PhD, Minal Mehta, MBBS, Danny Nguyen, MD, Joel W. Neal, MD, PhD
Format: Article
Language:English
Published: Elsevier 2023-10-01
Series:JTO Clinical and Research Reports
Subjects:
EGFR exon 20 insertions
Non–small cell lung cancer
Immunotherapy
Tyrosine kinase inhibitor therapy
Chemotherapy
Treatment outcome
Online Access:http://www.sciencedirect.com/science/article/pii/S2666364323001017

Internet

http://www.sciencedirect.com/science/article/pii/S2666364323001017

Similar Items